zavesca
Generic: miglustat
Labeler: actelion pharmaceuticals us, inc.Drug Facts
Product Profile
Brand Name
zavesca
Generic Name
miglustat
Labeler
actelion pharmaceuticals us, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
miglustat 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
66215-201
Product ID
66215-201_f9cb16ee-d325-b331-e053-6394a90ab08c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA021348
Listing Expiration
2026-12-31
Marketing Start
2003-07-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
66215201
Hyphenated Format
66215-201
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
zavesca (source: ndc)
Generic Name
miglustat (source: ndc)
Application Number
NDA021348 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 6 BLISTER PACK in 1 CARTON (66215-201-90) / 15 CAPSULE in 1 BLISTER PACK (66215-201-15)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f9cb16ee-d325-b331-e053-6394a90ab08c", "openfda": {"nui": ["N0000175783", "N0000020019", "N0000194077", "N0000194078"], "unii": ["ADN3S497AZ"], "rxcui": ["401938", "541070"], "spl_set_id": ["817892d1-ee12-4632-85fc-57ccdf16d7b8"], "pharm_class_epc": ["Glucosylceramide Synthase Inhibitor [EPC]", "Enzyme Stabilizer [EPC]"], "pharm_class_moa": ["Glucosylceramide Synthase Inhibitors [MoA]", "Enzyme Stabilizers [MoA]"], "manufacturer_name": ["Actelion Pharmaceuticals US, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (66215-201-90) / 15 CAPSULE in 1 BLISTER PACK (66215-201-15)", "package_ndc": "66215-201-90", "marketing_start_date": "20030731"}], "brand_name": "Zavesca", "product_id": "66215-201_f9cb16ee-d325-b331-e053-6394a90ab08c", "dosage_form": "CAPSULE", "pharm_class": ["Glucosylceramide Synthase Inhibitor [EPC]", "Glucosylceramide Synthase Inhibitors [MoA]"], "product_ndc": "66215-201", "generic_name": "miglustat", "labeler_name": "Actelion Pharmaceuticals US, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zavesca", "active_ingredients": [{"name": "MIGLUSTAT", "strength": "100 mg/1"}], "application_number": "NDA021348", "marketing_category": "NDA", "marketing_start_date": "20030731", "listing_expiration_date": "20261231"}